Naveris
Latest round
- Series A
Last raised
- Sep 2022
Total raised
- $52M
Investors
- 5
About Naveris
Naveris Inc. develops advanced blood testing technologies for early cancer detection, focusing on HPV-related malignancies.Founded in 2017 in Natick, US, Naveris Inc. specializes in blood testing for cancer detection.67 mn.Naveris specializes in advanced blood testing technologies aimed at the early detection of cancers, particularly focusing on human papillomavirus (HPV)-related malignancies. Their flagship product, NavDx®, utilizes a proprietary liquid biopsy method that analyzes tumor-tissue-modified DNA in blood plasma, allowing for highly sensitive detection of cancer in asymptomatic individuals and enabling real-time monitoring of treatment responses and identification of recurrence in patients in remission.Naveris operates a direct-to-consumer and B2B revenue model through its proprietary testing services, specifically the NavDx® test. Revenue is generated through partnerships with healthcare institutions and oncology clinics, which order tests for patients requiring cancer screening or monitoring. These transactions typically involve direct billing to healthcare providers or insurance reimbursement.In September 2022, Naveris Inc. The company is focused on introducing new testing technologies and expanding its reach into additional markets. Future plans include targeting further geographic regions within the healthcare sector to broaden its client base and enhance early cancer detection efforts.
Who invested in Naveris
5 investors across 3 rounds
See all investors in Naveris
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Naveris
Who invested in Naveris?
Naveris has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Naveris raised?
Naveris has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Naveris last raise money?
Naveris's most recent round on record is a Series A, in Sep 2022.
What does Naveris do?
Naveris is a biotechnology company.
Where is Naveris headquartered?
Naveris is headquartered in Natick, US.
Which VCs invest in companies like Naveris?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Naveris's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Naveris? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.